Stocktoria

Xenetic Biosciences, Inc. XBIO

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2016-11-07 · LEI

Xenetic Biosciences, Inc. statistics & valuation

Market cap$7.0M
P / S2.4×
P / B0.9×
Net margin-90.1%
Return on equity-36.2%
Return on capital-38.3%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-1806.90% -47.40% -74856.60% -2493.10% -486.40% -383.90% -162.80% -158.40% -90.10% 2016201720182019202020212022202320242025
Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
-1581.00% -47.10% -75511.70% -3189.80% -495.10% -393.60% -177.80% -168.20% -95.20% 2016201720182019202020212022202320242025
Return on equity (%)
-335.20% -25.10% -73.60% -74.20% -89.20% -30.70% -48.00% -42.20% -65.90% -36.20% 2016201720182019202020212022202320242025
Shares outstanding
4.6M 8.7M 783865 6.1M 8.7M 13.4M 1.5M 1.5M 1.5M 2.3M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-258.40% -18.80% -50.60% -59.30% -82.70% -28.50% -44.50% -39.00% -57.40% -32.10% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-293.50% 19.60% 2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
-$0.55 -$4.61 -$2.71 -$2.57 -$1.58 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin-95.2%-168.2%-177.8%-393.6%-495.1%-3189.8%-75511.7%—-47.1%-1581.0%
Net margin-90.1%-158.4%-162.8%-383.9%-486.4%-2493.1%-74856.6%—-47.4%-1806.9%
FCF margin————————19.6%-293.5%
Return on assets-32.1%-57.4%-39.0%-44.5%-28.5%-82.7%-59.3%-50.6%-18.8%-258.4%
Return on equity-36.2%-65.9%-42.2%-48.0%-30.7%-89.2%-74.2%-73.6%-25.1%-335.2%
Current ratio8.327.3711.8412.7213.1813.207.840.753.034.47

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.